Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer

Molecular Medicine Today

Volumn 5, Issue 2, 1999, Pages 86-94

  Van Steeg, Harry ^a   Kraemer, Kenneth H ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CLINICAL FEATURE; COCKAYNE SYNDROME; DISEASE ASSOCIATION; DNA DAMAGE; EXCISION REPAIR; HIGH RISK POPULATION; HUMAN; NONHUMAN; REVIEW; SKIN CANCER; TRICHOTHIODYSTROPHY; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

ANIMALS; DISEASE MODELS, ANIMAL; DNA DAMAGE; HUMANS; SKIN NEOPLASMS; SYNDROME; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM;

EID: 0033082322     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01394-X     Document Type: Review

References (53)

1. Kraemer K.H. Sunlight and skin cancer: another link revealed. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11-14.
2. Kripke M.L. Effects of UV radiation on tumor immunity. J. Natl. Cancer Inst. 82:1990;1392-1396.
3. Ljungman M., Zhang F. Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. Oncogene. 13:1996;823-831.
4. Mukhtar H., Elmets C.A. Photocarcinogenesis: mechanisms, models and human health implications. Photochem. Photobiol. 63:1996;356-357.
5. Bootsma, D., Kraemer, K.H., Cleaver, J.E., Hoeijmakers, J.H.J. (1998) Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy, in The Genetic Basis of Human Cancer (Vogelstein, B. and Kinzler, K.W., eds), pp. 245-274, McGraw-Hill.
6. Friedberg, E.C., Walker, G.C. and Siede, W. (1995) DNA Repair and Mutagenesis, ASM Press.
7. Hoeijmakers J.H.J. Nucleotide excision repair. II: From yeast to mammals. Trends Genet. 9:1993;211-217.
8. Sancar A. Mechanisms of DNA excision repair. Science. 266:1994;1954-1956.
9. Wood R.D. DNA repair in eukaryotes. Annu. Rev. Biochem. 65:1996;135-167.
10. Venema Jet al. The residual repair capacity of xeroderma pigmentosum complementation group C fibroblasts is highly specific for transcriptionally active DNA. Nucleic Acids Res. 18:1990;443-448.
11. Sugasawa Ket al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell. 2:1998;223-232.
12. Masutani Cet al. Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J. 13:1994;1831-1843.
13. Evans Eet al. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J. 16:1997;6559-6573.
14. Mu D., Wakasugi M., Hsu D.S., Sancar A. Characterization of reaction intermediates of human excision repair nuclease. J. Biol. Chem. 272:1997;28971-28979.
15. Schaeffer Let al. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science. 260:1993;58-63.
16. Hwang B.J., Liao J.C., Chu G. Isolation of a cDNA encoding a UV-damaged DNA binding factor defective in xeroderma pigmentosum group E cells. Mutat. Res. 362:1996;105-117.
17. Hanawalt P.C., Donahue B.A., Sweder K.S. Collision or collusion? Curr. Biol. 4:1994;518-521.
18. Van Gool A.Jet al. The Cockayne syndrome B protein, involved in transcription-coupled DNA repair, resides in an RNA polymerase II-containing complex. EMBO J. 16:1997;5955-5965.
19. Selby C.P., Sancar A. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11205-11209.
20. Iyer Net al. Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein. Biochemistry. 35:1996;2157-2167.
21. Selby C.P., Sancar A. Human transcription-repair coupling factor CSB/ERCC6 is a DNA-stimulated ATPase but is not a helicase and does not disrupt the ternary transcription complex of stalled RNA polymerase II. J. Biol. Chem. 272:1997;1885-1890.
22. Li L.et al. Specific association between the human DNA repair proteins XPA and ERCC1. Proc. Natl. Acad. Sci. U. S. A. 91:1994;5012-5016.
23. Kraemer, K.H. (1977) Progressive degenerative diseases associated with defective DNA repair: xeroderma pigmentosum and ataxia telangiectasia, in DNA Repair Processes (Nichols, W.W. et al., eds), pp. 37-71, Symposium Specialists.
24. Reardon J.T.et al. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. U. S. A. 94:1997;9463-9468.
25. Nance M.A., Berry S.A. Cockayne syndrome: review of 140 cases. Am. J. Med. Genet. 42:1992;68-84.
26. Taylor E.M.et al. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc. Natl. Acad. Sci. U. S. A. 94:1997;8658-8663.
27. International Agency for Research on Cancer (1992) Solar and ultraviolet radiation, in Monographs On The Evaluation Of Carcinogenic Risks To Humans (Vol. 55), IARC.
28. Mitchell D.L., Nairn R.S. The biology of the (6-4) photoproduct. Photochem. Photobiol. 49:1989;805-819.
29. Hanawalt P.C. Heterogeneity of DNA repair at the gene level. Mutat. Res. 247:1991;203-211.
30. Hall P.A.et al. High levels of p53 protein in UV-irradiated normal human skin. Oncogene. 8:1993;203-207.
31. Harris C.C. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environ. Health Perspect. 104:1996;435-439.
32. Brash D.E.et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A. 88:1991;10124-10128.
33. Daya-Grosjean L., Dumaz N., Sarasin A. The specificity of p53 mutation spectra in sunlight induced human cancers. J. Photochem. Photobiol. 28:1995;115-124.
34. Dumaz N., Drougard C., Sarasin A., Daya-Grosjean L. Specific UV- induced mutation spectrum in the p53 gene of skin tumors from DNA-repair- deficient xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10529-10533.
35. Giglia Get al. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res. 58:1998;4402-4409.
36. Parris C.N., Kraemer K.H. Ultraviolet-induced mutations in Cockayne syndrome cells are primarily caused by cyclobutane dimer photoproducts while repair of other photoproducts is normal. Proc. Natl. Acad. Sci. U. S. A. 90:1993;7260-7264.
37. Eveno E.et al. Different removal of ultraviolet photoproducts in genetically related xeroderma pigmentosum and trichothiodystrophy diseases. Cancer Res. 55:1995;4325-4332.
38. Marionnet C., Armier J., Sarasin A., Stary A. Cyclobutane pyrimidine dimers are the main mutagenic DNA photoproducts in DNA repair-deficient trichothiodystrophy cells. Cancer Res. 58:1998;102-108.
39. Kripke M.L. Ultraviolet radiation and immunology: something new under the sun-presidential address. Cancer Res. 54:1994;6102-6105.
40. Mariani E.et al. Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy. Clin. Exp. Immunol. 88:1992;376-382.
41. Gaspari A.A., Fleisher T.A., Kraemer K.H. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J. Clin. Invest. 92:1993;1135-1142.
42. Jimbo T., Ichihashi M., Mishima Y., Fujiwara Y. Role of excision repair in UVB-induced depletion and recovery of human epidermal Langerhans cells. Arch. Dermatol. 128:1992;61-67.
43. Miyauchi-Hashimoto H., Tanaka K., Horio T. Enhanced inflammation and immunosuppression by ultraviolet radiation in xeroderma pigmentosum group A (XPA) model mice. J. Invest. Dermatol. 107:1996;343-348.
44. Sands A.T.et al. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature. 377:1995;162-165.
45. Nakane H.et al. High incidence of ultraviolet-B- or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature. 377:1995;165-168.
46. de Vries A.et al. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. ature. 377:1995;169-173.
47. Berg R.J.W.et al. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema. J. Invest. Dermatol. 110:1998;405-409.
48. de Vries A.et al. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B. Oncogene. 16:1998;2205-2212.
49. Takeuchi S.et al. Strand specificity and absence of hot spots for p53 mutations in ultraviolet B-induced skin tumors of XPA-deficient mice. Cancer Res. 58:1998;641-646.
50. Cheo D.L.et al. Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat. Res. 374:1997;1-9.
51. van der Horst G.T.J.et al. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell. 89:1997;425-435.
52. de Boer J.et al. Disruption of the mouse xeroderma pigmentosum group D DNA repair/basal transcription gene results in preimplantation lethality. Cancer Res. 58:1998;89-94.
53. de Boer J.et al. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol. Cell. 1:1998;981-990.